Pharmabiz

Union govt to focus on quality-driven healthcare system for every citizen highlighted at FICCI HEAL 2025

Union govt to focus on quality-driven healthcare system for every citizen highlighted at FICCI HEAL 2025: Our Bureau, Bengaluru Thursday, October 9, 2025, 17:40 Hrs [IST] Union go ...
Pharmabiz

Union government working to achieve equitable, accessible and affordable healthcare by 2047

Union government working to achieve equitable, accessible and affordable healthcare by 2047: Our Bureau, Bengaluru Thursday, October 9, 2025, 17:15 Hrs [IST] Union government is n ...
Pharmabiz

PharmaJet expands its injection portfolio with development of needle-free self-injection pens for home use

PharmaJet expands its injection portfolio with development of needle-free self-injection pens for home use: Golden, Colombia Thursday, October 9, 2025, 15:00 Hrs [IST] PharmaJet, ...
Pharmabiz

US FDA grants orphan drug designation to Precision NeuroMed’s investigational therapy for glioblastoma

US FDA grants orphan drug designation to Precision NeuroMed’s investigational therapy for glioblastoma: Redwood City, California Thursday, October 9, 2025, 16:00 Hrs [IST] Preci ...
Pharmabiz

Lupin unveils strategic partnership programme to expand reach of its long-acting injectable platform

Lupin unveils strategic partnership programme to expand reach of its long-acting injectable platform: Our Bureau, Mumbai Thursday, October 9, 2025, 16:15 Hrs [IST] Global pharma m ...
Pharmabiz

Kauvery Hospital Alwarpet achieves JCI accreditation, strengthening Chennai’s position as Asia’s healthcare capital

Kauvery Hospital Alwarpet achieves JCI accreditation, strengthening Chennai’s position as Asia’s healthcare capital: Our Bureau, Mumbai Thursday, October 9, 2025, 15:30 Hrs [I ...
Pharmabiz

MaaT Pharma reports positive second safety interim analysis from DSMB for phase 2b PHOEBUS trial of MaaT033 for patients receiving Allo-HSCT

MaaT Pharma reports positive second safety interim analysis from DSMB for phase 2b PHOEBUS trial of MaaT033 for patients receiving Allo-HSCT: Lyon, France Thursday, October 9, 202 ...
Pharmabiz

DCOIWA observes Black Day against suspension of drug regulatory officers in MP

DCOIWA observes Black Day against suspension of drug regulatory officers in MP: Our Bureau, Chennai Thursday, October 9, 2025, 15:45 Hrs [IST] Members of the Drugs Control Officer ...
Pharmabiz

Kernal Biologics receives $48 million fund from ARPA-H to develop lower cost in vivo CAR T-cell therapies for hematological cancers

Kernal Biologics receives $48 million fund from ARPA-H to develop lower cost in vivo CAR T-cell therapies for hematological cancers: Boston Thursday, October 9, 2025, 13:00 Hrs [I ...
Pharmabiz

J&J unveils new data demonstrating superior clarity of vision and comfort of ACUVUE OASYS MAX 1-Day for Astigmatism, and Multifocal for Astigmatism contact lenses

Jacksonville, Florida Thursday, October 9, 2025, 12:00 Hrs [IST] ...
Pharmabiz

Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD

Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD: Munich, Germany Thursday, October 9, 2025, 11 ...
Pharmabiz

CND Life Sciences receives US FDA breakthrough device designation for its skin biopsy-based Syn-One Test

Scottsdale, Arizona Thursday, October 9, 2025, 10:00 Hrs [IST] ...